CO5021131A1 - Compuestos de nuevas 1,2-dihidro-indazol-3-ona 1,2,5-trisus- tituidas, procedimiento para prepararlos; uso de dichos com- puestos por sus efectos antiasmaticos, antialergicos, anti- inflamatorios, inmunomoduladores y neuroprotectores y compo- sicione - Google Patents

Compuestos de nuevas 1,2-dihidro-indazol-3-ona 1,2,5-trisus- tituidas, procedimiento para prepararlos; uso de dichos com- puestos por sus efectos antiasmaticos, antialergicos, anti- inflamatorios, inmunomoduladores y neuroprotectores y compo- sicione

Info

Publication number
CO5021131A1
CO5021131A1 CO99028290A CO99028290A CO5021131A1 CO 5021131 A1 CO5021131 A1 CO 5021131A1 CO 99028290 A CO99028290 A CO 99028290A CO 99028290 A CO99028290 A CO 99028290A CO 5021131 A1 CO5021131 A1 CO 5021131A1
Authority
CO
Colombia
Prior art keywords
compounds
choh
indazol
trisus
tituids
Prior art date
Application number
CO99028290A
Other languages
English (en)
Inventor
Rudolf Schindler
Norbert Horgen
Brune Kay
Original Assignee
Rzneimittelwerk Dresden Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rzneimittelwerk Dresden Gmbh filed Critical Rzneimittelwerk Dresden Gmbh
Publication of CO5021131A1 publication Critical patent/CO5021131A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compuestos de 1,2-dihidro- indazol-3-ona 1,2,5-trisustituidascaracterizados porque tienen la fórmula general Idonde X, Y, Z, R1 , R2 y R3 tienen el siguiente significado:X puede ser -SO2 -, -SO-, -(CH2 )p -, -(CH2 )p -O-, -(CH2 )p -(C=O)- -(CH2 )p - (C=O)-NH, -(CH2 )p -CHOH-, -CHOH-(CH2 )p -, -(CH2 )p -CH=CH-, CH=CH-(CH2 )p - con p = 1...4,Y puede ser -(C=O)-, -(C=O)-NH, -(C=O)-NH-(CH2 )p -, -(C=O)-(CH2 )p- , -(CH2 )p -, -(CH2 )p -O-, -(CH2 )p -(C=O), -(CH2 )p -(C=O)-NH-, -(CH2 )p-(C=O)-NH- (CH2 )p -, -(CH2 )p -CHOH, -CHOH-(CH2 )p -, -(CH2 )p -CH=CH, -CH=CH-(CH2 )p - con p = 1...4, Z puede ser -O-, -O-(CH2 )p - con p = 1...4, -NH-, -NH-(C=O), -NH-(C=O)-NH, -NH(C=O)-O-, -NH-CH2 -(C=O)- y -NH-(C=O)-CH2 ,R1 , R2 y R3 pueden ser iguales o diferentes y pueden tener el siguiente significado:Carbociclos mono, bi o tricíclicos saturados o una o más veces insaturados, con 5...14 eslabones especialmente fenilo, naftilo, antranilo, fluorenilo; o heterociclos mono, bi o tricíclicos saturados o una o más veces insaturados, con 5-15 eslabones y 1...6 heteroátomos que preferentemente son N, O y S, especialmente tiofenilo, piridinilo, isoxazolilo, benzimidazolilo, benz [1,3] dioxolilo, pirimidinilo, quinolilo, quinazolinilo, morfolinilo, pirrolidinilo, pirrolilo, fenil [1,2,4]oxadiazolilo, feniltiazolilo, donde los carbociclos o en su caso, los heterociclos pueden estar una o más veces sustituidos por ...
CO99028290A 1998-05-11 1999-05-07 Compuestos de nuevas 1,2-dihidro-indazol-3-ona 1,2,5-trisus- tituidas, procedimiento para prepararlos; uso de dichos com- puestos por sus efectos antiasmaticos, antialergicos, anti- inflamatorios, inmunomoduladores y neuroprotectores y compo- sicione CO5021131A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19821003A DE19821003A1 (de) 1998-05-11 1998-05-11 Neue 1,2,5-trisubstituierte 1,2-dihydro-indazol-3-one mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
CO5021131A1 true CO5021131A1 (es) 2001-03-27

Family

ID=7867363

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99028290A CO5021131A1 (es) 1998-05-11 1999-05-07 Compuestos de nuevas 1,2-dihidro-indazol-3-ona 1,2,5-trisus- tituidas, procedimiento para prepararlos; uso de dichos com- puestos por sus efectos antiasmaticos, antialergicos, anti- inflamatorios, inmunomoduladores y neuroprotectores y compo- sicione

Country Status (23)

Country Link
US (1) US6180637B1 (es)
EP (1) EP1077948A1 (es)
JP (1) JP2002514627A (es)
KR (1) KR20010025011A (es)
CN (1) CN1309642A (es)
AR (1) AR018605A1 (es)
AU (1) AU745796B2 (es)
BG (1) BG104910A (es)
BR (1) BR9911772A (es)
CA (1) CA2271837A1 (es)
CO (1) CO5021131A1 (es)
DE (1) DE19821003A1 (es)
HK (1) HK1038751A1 (es)
HU (1) HUP0101707A3 (es)
IL (1) IL139358A0 (es)
NO (1) NO20005698L (es)
NZ (1) NZ508646A (es)
PL (1) PL344254A1 (es)
SK (1) SK17082000A3 (es)
TR (1) TR200003302T2 (es)
TW (1) TW448163B (es)
WO (1) WO1999058504A1 (es)
ZA (1) ZA200006151B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6417189B1 (en) * 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
WO2008141385A1 (en) * 2007-05-21 2008-11-27 Biota Scientific Management Pty Ltd Viral polymerase inhibitors
SG193454A1 (en) 2011-03-14 2013-10-30 Boehringer Ingelheim Int Benzodioxane inhibitors of leukotriene production
WO2013012844A1 (en) 2011-07-19 2013-01-24 Boehringer Ingelheim International Gmbh Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase
TW201350475A (zh) 2012-03-06 2013-12-16 Boehringer Ingelheim Int 用於組合療法之白三烯素生成之苯并二噁烷抑制劑
US8946203B2 (en) 2012-03-06 2015-02-03 Boehringer Ingelheim International Gmbh Benzodioxane inhibitors of leukotriene production
JP6256467B2 (ja) 2012-07-17 2018-01-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン生成を阻害するピラゾール誘導体
JP2016523982A (ja) 2013-07-15 2016-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン生成の阻害剤
EP3022193B1 (en) 2013-07-15 2017-04-26 Boehringer Ingelheim International GmbH Inhibitors of leukotriene production
KR20190017873A (ko) * 2016-06-08 2019-02-20 썬리겐 헬쓰케어 아게 홀수의 탄소 원자를 갖는 지질 및 제약 조성물 또는 영양 보충제로서의 그의 용도
CN113105409B (zh) * 2021-04-06 2023-06-02 四川大学 2-(羟基苄基)苯并[d]异噻唑酮类化合物、其制备方法和用途
CA3221177A1 (en) 2021-11-01 2023-05-04 Meghan Kerrisk Campbell Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3132916A1 (de) * 1981-08-20 1983-03-03 Kali-Chemie Pharma Gmbh, 3000 Hannover 1-phenylindazol-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5179112A (en) * 1985-04-17 1993-01-12 Ici Americas Inc. Heterocyclic amide derivatives and pharmaceutical use
IL84944A (en) * 1987-01-19 1992-02-16 Ici Plc Pharmaceutical compositions containing 1,2-dihydro-3h-indazolone derivatives,some new such compounds and their preparation
US5036083A (en) * 1988-07-15 1991-07-30 Ici Pharma Heterocyclic agents
US5229408A (en) * 1988-07-15 1993-07-20 Ici Pharma 4-carbamoyl-1,2-dihydro-3H-indazol-3-one derivatives
DE19610882A1 (de) * 1996-03-20 1997-09-25 Dresden Arzneimittel Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
HUP0101707A2 (hu) 2002-03-28
NO20005698D0 (no) 2000-11-10
ZA200006151B (en) 2000-12-06
NZ508646A (en) 2002-11-26
HUP0101707A3 (en) 2002-06-28
DE19821003A1 (de) 1999-11-18
CA2271837A1 (en) 1999-11-11
JP2002514627A (ja) 2002-05-21
WO1999058504A9 (de) 2000-02-03
SK17082000A3 (sk) 2001-09-11
AU745796B2 (en) 2002-03-28
TW448163B (en) 2001-08-01
CN1309642A (zh) 2001-08-22
AU4257699A (en) 1999-11-29
BG104910A (en) 2001-06-29
WO1999058504A1 (de) 1999-11-18
PL344254A1 (en) 2001-10-22
IL139358A0 (en) 2001-11-25
BR9911772A (pt) 2001-02-06
NO20005698L (no) 2001-01-08
AR018605A1 (es) 2001-11-28
EP1077948A1 (de) 2001-02-28
HK1038751A1 (zh) 2002-03-28
TR200003302T2 (tr) 2001-02-21
KR20010025011A (ko) 2001-03-26
US6180637B1 (en) 2001-01-30

Similar Documents

Publication Publication Date Title
CO5021131A1 (es) Compuestos de nuevas 1,2-dihidro-indazol-3-ona 1,2,5-trisus- tituidas, procedimiento para prepararlos; uso de dichos com- puestos por sus efectos antiasmaticos, antialergicos, anti- inflamatorios, inmunomoduladores y neuroprotectores y compo- sicione
CO5060424A1 (es) Nuevos 1h-indazoles 1,5 y 3-0 sustituidos con efecto antias- matico, antialergico, antiinflamatorio, inmunomodulador y neuroprotector, procedimientos para su elaboracion y su aplicacion como medicamentos
ES2170400T3 (es) Composiciones adhesivas termoplasticas hidrofilas.
CY1118652T1 (el) Συνθεσεις που περιεχουν φθοριο-υποκατεστημενες ολεφινες
AR005742A1 (es) Copolimeros de bloques utilizables para composiciones adhesivas por colada caliente curables por radiacion, proceso para prepararlos, composiciones adhesivas, sellantes y de revestimiento, particularmente curadas por radiacion, que los comprenden, y cintas o rotulos sensibles a la presion curables por radiacion que comprenden a dicha composicion adhesiva
DE50008093D1 (de) Leuchtstoffanordnung wellenlängenkonvertierende vergussmasse und lichtquelle
GT199900022A (es) Compuestos para el tratamiento de la isquemia
MX170224B (es) Composiciones de filtro solar
ES2196026T3 (es) Uso de ndv en la fabricacion de un medicamento para tratar el cancer.
BR0309063A (pt) Composição amaciante de tecido e métodos para fabricação e uso
BR0016166A (pt) Compostos de diidropirimidina heterocìclicos
AR010310A1 (es) Derivados de pirazol sustituidos, procedimiento para su preparacion, medicamentos que los comprenden, procedimiento para su produccion, uso de los mismos para la produccion de medicamentos.
ATE273361T1 (de) 1,1,1,3,3-pentafluorbutan enthaltende zusammensetzungen und deren verwendung
ES2092585T3 (es) Polioxazolidinas con grupos carbonato, procedimiento para su preparacion y su empleo.
AU5313694A (en) Hair dye composition
DE69918689D1 (de) Verwendung eines antimikrobiellen mittels
ATE541988T1 (de) Triazinylaminostilbendisulfonsäuremischungen
MX167422B (es) Composiciones y metodo para tratar una formacion subterranea
NO930863D0 (no) Randomiserte kopolymermaterialer av propylen med et alfa-olefin som komonomer, og en fremgangsmaate for fremstilling av slike
TR199901188T1 (xx) Aromatik veya heteroaromatik radikal ile de�i�tirilmi� bifenil t�revleri, ve bunlar� i�eren farmas�tik ve kozmetik bile�imler.
ES2187070T3 (es) Composiciones de laca para el cabello autofobas.
AR035997A1 (es) Composiciones poliolefinicas para peliculas con propiedades antinebulosidad permanentes y el uso de la misma
AR033242A1 (es) Composicion de revestimiento
ES2099024B1 (es) Nuevos derivados de 2,2,6,6-tetrametil-4-piperidinol para su uso como estabilizantes a la luz, estabilizantes al calor, y estabilizantes a la oxidacion para materiales organicos.
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.